Bio-Rad Laboratories EBITDA Margin 2012-2025 | BIO
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Bio-Rad Laboratories (BIO) over the last 10 years. The current EBITDA margin for Bio-Rad Laboratories as of December 31, 2025 is .
| Bio-Rad Laboratories EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2025-09-30 | $2.56B | $0.22B | 8.76% |
| 2025-06-30 | $2.56B | $0.22B | 8.77% |
| 2025-03-31 | $2.54B | $0.25B | 9.80% |
| 2024-12-31 | $2.57B | $0.27B | 10.51% |
| 2024-09-30 | $2.58B | $0.31B | 11.89% |
| 2024-06-30 | $2.56B | $0.33B | 12.99% |
| 2024-03-31 | $2.61B | $0.32B | 12.32% |
| 2023-12-31 | $2.67B | $0.34B | 12.65% |
| 2023-09-30 | $2.72B | $0.36B | 13.31% |
| 2023-06-30 | $2.77B | $0.37B | 13.22% |
| 2023-03-31 | $2.78B | $0.40B | 14.36% |
| 2022-12-31 | $2.80B | $0.48B | 17.24% |
| 2022-09-30 | $2.81B | $0.48B | 17.18% |
| 2022-06-30 | $2.87B | $0.54B | 18.95% |
| 2022-03-31 | $2.90B | $0.55B | 18.85% |
| 2021-12-31 | $2.92B | $0.50B | 17.14% |
| 2021-09-30 | $2.98B | $0.57B | 19.09% |
| 2021-06-30 | $2.88B | $0.52B | 18.13% |
| 2021-03-31 | $2.70B | $0.45B | 16.62% |
| 2020-12-31 | $2.55B | $0.42B | 16.58% |
| 2020-09-30 | $2.38B | $0.30B | 12.39% |
| 2020-06-30 | $2.29B | $0.24B | 10.55% |
| 2020-03-31 | $2.33B | $0.25B | 10.56% |
| 2019-12-31 | $2.31B | $0.23B | 9.90% |
| 2019-09-30 | $2.31B | $-0.06B | -2.47% |
| 2019-06-30 | $2.29B | $-0.04B | -1.88% |
| 2019-03-31 | $2.29B | $-0.06B | -2.40% |
| 2018-12-31 | $2.29B | $-0.07B | -2.97% |
| 2018-09-30 | $2.29B | $0.22B | 9.37% |
| 2018-06-30 | $2.28B | $0.22B | 9.55% |
| 2018-03-31 | $2.21B | $0.21B | 9.45% |
| 2017-12-31 | $2.16B | $0.23B | 10.42% |
| 2017-09-30 | $2.11B | $0.15B | 7.01% |
| 2017-06-30 | $2.09B | $0.14B | 6.76% |
| 2017-03-31 | $2.10B | $0.17B | 7.92% |
| 2016-12-31 | $2.07B | $0.17B | 8.03% |
| 2016-09-30 | $2.07B | $0.25B | 11.90% |
| 2016-06-30 | $2.03B | $0.21B | 10.45% |
| 2016-03-31 | $2.02B | $0.19B | 9.51% |
| 2015-12-31 | $2.02B | $0.17B | 8.22% |
| 2015-09-30 | $2.05B | $0.16B | 7.72% |
| 2015-06-30 | $2.11B | $0.16B | 7.50% |
| 2015-03-31 | $2.14B | $0.16B | 7.67% |
| 2014-12-31 | $2.18B | $0.15B | 6.90% |
| 2014-09-30 | $2.18B | $0.15B | 6.93% |
| 2014-06-30 | $2.15B | $0.15B | 6.82% |
| 2014-03-31 | $2.14B | $0.15B | 7.19% |
| 2013-12-31 | $2.13B | $0.17B | 7.92% |
| 2013-09-30 | $2.10B | $0.19B | 8.94% |
| 2013-06-30 | $2.10B | $0.23B | 10.72% |
| 2013-03-31 | $2.08B | $0.25B | 11.76% |
| 2012-12-31 | $2.07B | $0.26B | 12.76% |
| 2012-09-30 | $2.05B | $0.29B | 14.13% |
| 2012-06-30 | $2.06B | $0.30B | 14.40% |
| 2012-03-31 | $2.08B | $0.29B | 14.07% |
| 2011-12-31 | $2.07B | $0.31B | 14.71% |
| 2011-09-30 | $2.06B | $0.29B | 13.95% |
| 2011-06-30 | $2.01B | $0.29B | 14.31% |
| 2011-03-31 | $1.96B | $0.29B | 14.70% |
| 2010-12-31 | $1.93B | $0.28B | 14.73% |
| 2010-09-30 | $1.89B | $0.26B | 13.87% |
| 2010-06-30 | $1.88B | $0.25B | 13.53% |
| 2010-03-31 | $1.84B | $0.24B | 13.17% |
| 2009-12-31 | $1.78B | $0.23B | 12.89% |
| 2009-09-30 | $1.74B | $0.20B | 11.28% |
| 2009-06-30 | $1.72B | $0.18B | 10.48% |
| 2009-03-31 | $1.74B | $0.18B | 10.56% |
| 2008-12-31 | $1.76B | $0.18B | 10.37% |
| 2008-09-30 | $1.78B | $0.18B | 10.36% |
| 2008-06-30 | $1.67B | $0.17B | 10.22% |
| 2008-03-31 | $1.56B | $0.15B | 9.42% |
| 2007-12-31 | $1.46B | $0.14B | 9.30% |
| 2007-09-30 | $1.35B | $0.14B | 10.33% |
| 2007-06-30 | $1.31B | $0.13B | 10.00% |
| 2007-03-31 | $1.29B | $0.14B | 10.71% |
| 2006-12-31 | $1.27B | $0.15B | 11.46% |
| 2006-09-30 | $1.24B | $0.14B | 11.47% |
| 2006-06-30 | $1.22B | $0.14B | 11.27% |
| 2006-03-31 | $1.19B | $0.12B | 10.26% |
| 2005-12-31 | $1.18B | $0.12B | 9.75% |
| 2005-09-30 | $1.18B | $0.10B | 8.81% |
| 2005-06-30 | $1.16B | $0.11B | 9.08% |
| 2005-03-31 | $1.13B | $0.11B | 9.85% |
| 2004-12-31 | $1.09B | $0.11B | 9.99% |
| 2004-09-30 | $1.04B | $0.13B | 12.64% |
| 2004-06-30 | $1.02B | $0.14B | 13.64% |
| 2004-03-31 | $1.00B | $0.14B | 14.14% |
| 2003-12-31 | $0.98B | $0.15B | 15.00% |
| 2003-09-30 | $0.94B | $0.15B | 15.71% |
| 2003-06-30 | $0.93B | $0.15B | 16.22% |
| 2003-03-31 | $0.90B | $0.15B | 16.32% |
| 2002-12-31 | $0.87B | $0.14B | 15.95% |
| 2002-09-30 | $0.88B | $0.13B | 15.18% |
| 2002-06-30 | $0.84B | $0.12B | 14.10% |
| 2002-03-31 | $0.82B | $0.11B | 13.47% |
| 2001-12-31 | $0.82B | $0.11B | 12.97% |
| 2001-09-30 | $0.76B | $0.09B | 11.29% |
| 2001-06-30 | $0.75B | $0.08B | 10.64% |
| 2001-03-31 | $0.74B | $0.07B | 9.81% |
| 2000-12-31 | $0.73B | $0.06B | 8.40% |
| 2000-09-30 | $0.74B | $0.06B | 8.49% |
| 2000-06-30 | $0.68B | $0.04B | 6.47% |
| 2000-03-31 | $0.61B | $0.04B | 7.22% |
| 1999-12-31 | $0.55B | $0.05B | 8.73% |
| 1999-09-30 | $0.48B | $0.03B | 6.32% |
| 1999-06-30 | $0.46B | $0.04B | 8.91% |
| 1999-03-31 | $0.45B | $0.04B | 7.74% |
| 1998-12-31 | $0.44B | $0.03B | 7.01% |
| 1998-09-30 | $0.44B | $0.03B | 6.61% |
| 1998-06-30 | $0.44B | $0.04B | 8.88% |
| 1998-03-31 | $0.44B | $0.03B | 6.86% |
| 1997-12-31 | $0.43B | $0.03B | 6.32% |
| 1997-09-30 | $0.43B | $0.03B | 7.53% |
| 1997-06-30 | $0.42B | $0.03B | 6.62% |
| 1997-03-31 | $0.42B | $0.04B | 9.35% |
| 1996-12-31 | $0.42B | $0.04B | 10.02% |
| 1996-09-30 | $0.41B | $0.06B | 13.32% |
| 1996-06-30 | $0.41B | $0.05B | 12.22% |
| 1996-03-31 | $0.41B | $0.05B | 11.06% |
| 1995-12-31 | $0.40B | $0.04B | 10.08% |
| 1995-09-30 | $0.39B | $0.04B | 10.10% |
| 1995-06-30 | $0.38B | $0.04B | 10.08% |
| 1995-03-31 | $0.36B | $0.04B | 10.44% |
| 1994-12-31 | $0.36B | $0.04B | 10.11% |
| 1994-09-30 | $0.35B | $0.03B | 9.25% |
| 1994-06-30 | $0.34B | $0.03B | 7.92% |
| 1994-03-31 | $0.34B | $0.02B | 6.21% |
| 1993-12-31 | $0.33B | $0.02B | 4.56% |
| 1993-09-30 | $0.33B | $0.02B | 7.27% |
| 1993-06-30 | $0.33B | $0.03B | 7.58% |
| 1993-03-31 | $0.33B | $0.02B | 5.79% |
| 1992-12-31 | $0.33B | $0.02B | 7.25% |
| 1992-09-30 | $0.33B | $0.02B | 4.62% |
| 1992-06-30 | $0.32B | $0.02B | 5.30% |
| 1992-03-31 | $0.32B | $0.03B | 7.86% |
| 1991-12-31 | $0.31B | $0.02B | 7.40% |
| 1991-09-30 | $0.31B | $0.03B | 8.41% |
| 1991-06-30 | $0.30B | $0.03B | 8.22% |
| 1991-03-31 | $0.30B | $0.03B | 8.45% |
| 1990-12-31 | $0.29B | $0.02B | 8.36% |
| 1990-09-30 | $0.27B | $0.02B | 7.35% |
| 1990-06-30 | $0.26B | $0.02B | 7.78% |
| 1990-03-31 | $0.25B | $0.02B | 8.47% |
| 1989-12-31 | $0.24B | $0.02B | 8.90% |
| 1989-09-30 | $0.22B | $0.02B | 9.38% |
| 1989-06-30 | $0.22B | $0.02B | 9.30% |
| 1989-03-31 | $0.20B | $0.02B | 9.80% |
| 1988-12-31 | $0.20B | $0.02B | 10.05% |
| 1988-09-30 | $0.19B | $0.02B | 10.53% |
| 1988-06-30 | $0.18B | $0.02B | 10.93% |
| 1988-03-31 | $0.17B | $0.02B | 10.98% |
| 1987-12-31 | $0.16B | $0.02B | 10.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $6.921B | $2.583B |
| Bio-Rad Laboratories is a manufacturer and global supplier of clinical diagnostics and life science research products in the healthcare, analytical chemistry life science research and other markets. It offers a wide portfolio of products and systems which allow the separation of complex chemical and biological materials and discovery, analysis and purification of their components. Bio-Rad has extensive and direct distribution channels outside the United States through subsidiaries which focus on sales, customer service and product distribution. The company operates through two reportable segments - Life Science segment which designs, manufactures, markets and services reagents, apparatus and instruments utilized for biological research. Clinical Diagnostics - This business markets and distributes products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians office laboratories, transfusion laboratories as well as insurance and forensic testing laboratories. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $195.936B | 21.88 |
| EssilorLuxottica (ESLOY) | France | $142.091B | 0.00 |
| Stryker (SYK) | United States | $140.083B | 26.86 |
| Medtronic (MDT) | Ireland | $127.548B | 17.67 |
| Boston Scientific (BSX) | United States | $110.783B | 24.50 |
| Medline (MDLN) | United States | $58.526B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $48.093B | 0.00 |
| ResMed (RMD) | United States | $36.791B | 24.57 |
| GE HealthCare Technologies (GEHC) | United States | $36.615B | 17.54 |
| Agilent Technologies (A) | United States | $35.584B | 22.55 |
| Koninklijke Philips (PHG) | Netherlands | $30.091B | 17.86 |
| Terumo (TRUMY) | Japan | $21.610B | 25.26 |
| Zimmer Biomet Holdings (ZBH) | United States | $19.115B | 11.76 |
| Insulet (PODD) | United States | $17.076B | 53.00 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $15.372B | 0.00 |
| Baxter (BAX) | United States | $10.182B | 8.72 |
| Sunny Optical Technology (SNPTF) | China | $8.485B | 0.00 |
| Demant (WILYY) | Denmark | $6.042B | 0.00 |
| Envista Holdings (NVST) | United States | $4.747B | 24.14 |
| Lantheus Holdings (LNTH) | United States | $4.601B | 14.02 |
| BillionToOne (BLLN) | United States | $4.056B | 0.00 |
| ICU Medical (ICUI) | United States | $3.577B | 22.71 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.263B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $3.160B | 14.91 |
| Haemonetics (HAE) | United States | $2.684B | 11.74 |
| Neogen (NEOG) | United States | $2.380B | 52.10 |
| Phibro Animal Health (PAHC) | United States | $2.118B | 18.66 |
| Perrigo (PRGO) | Ireland | $2.001B | 5.01 |
| LeMaitre Vascular (LMAT) | United States | $1.989B | 40.03 |
| Curaleaf Holdings (CURLF) | Canada | $1.642B | 0.00 |
| AtriCure (ATRC) | United States | $1.623B | 0.00 |
| QuidelOrtho (QDEL) | United States | $1.602B | 11.12 |
| Kestra Medical Technologies (KMTS) | United States | $1.571B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.446B | 63.36 |
| AdaptHealth (AHCO) | United States | $1.381B | 20.00 |
| Lumexa Imaging Holdings (LMRI) | United States | $1.358B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.070B | 317.57 |
| Capricor Therapeutics (CAPR) | United States | $1.026B | 0.00 |
| InMode (INMD) | Israel | $0.906B | 9.93 |
| Tilray Brands (TLRY) | Canada | $0.875B | 0.00 |
| Valneva SE (VALN) | France | $0.868B | 0.00 |
| Omeros (OMER) | United States | $0.829B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.757B | 0.00 |
| CeriBell (CBLL) | United States | $0.733B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.566B | 13.52 |
| Brainsway (BWAY) | Israel | $0.451B | 76.63 |
| Canopy Growth (CGC) | Canada | $0.436B | 0.00 |
| Cerus (CERS) | United States | $0.430B | 0.00 |
| Verano Holdings (VRNO) | United States | $0.396B | 0.00 |
| SNDL (SNDL) | Canada | $0.386B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.361B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.328B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.315B | 25.09 |
| Evolus (EOLS) | United States | $0.279B | 0.00 |
| Quanterix (QTRX) | United States | $0.268B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.243B | 0.00 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| Sanuwave Health (SNWV) | United States | $0.213B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.205B | 18.42 |
| High Tide (HITI) | Canada | $0.203B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.201B | 59.17 |
| OraSure Technologies (OSUR) | United States | $0.197B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.182B | 0.00 |
| Organigram Global (OGI) | Canada | $0.174B | 0.00 |
| Accendra Health (ACH) | United States | $0.173B | 1.74 |
| Vireo Growth (VREOF) | United States | $0.170B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.168B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.157B | 0.00 |
| Apyx Medical (APYX) | United States | $0.142B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.134B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.129B | 0.00 |
| Fonar (FONR) | United States | $0.115B | 16.42 |
| MacroGenics (MGNX) | United States | $0.108B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.100B | 0.00 |
| Biote (BTMD) | United States | $0.097B | 4.26 |
| Exagen (XGN) | United States | $0.074B | 0.00 |
| ImmuCell (ICCC) | United States | $0.060B | 25.39 |
| Sharps Technology (STSS) | United States | $0.051B | 0.00 |
| Nephros (NEPH) | United States | $0.044B | 31.54 |
| Cytosorbents (CTSO) | United States | $0.040B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.040B | 0.00 |
| Veru (VERU) | United States | $0.037B | 0.00 |
| Modular Medical (MODD) | United States | $0.035B | 0.00 |
| United-Guardian (UG) | United States | $0.030B | 15.35 |
| Jin Medical (ZJYL) | China | $0.022B | 0.00 |
| Bonk (BNKK) | United States | $0.021B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.014B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.014B | 0.00 |
| Flora Growth (FLGC) | United States | $0.009B | 0.00 |
| INLIF (INLF) | China | $0.007B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.006B | 0.00 |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| Functional Brands (MEHA) | United States | $0.003B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| Agape ATP (ATPC) | $0.002B | 0.00 | |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |